Inventor · disambiguated record
Robyn Puro
Also filed as: PURO ROBYN · PURO ROBYN J
6 granted patents·14 pending applications·20 citations·filing 2014–2022
77Inventor score
Files withARCH ONCOLOGY INC15DECIMMUNE THERAPEUTICS INC3DECLMMUNE THERAPEUTICS INC1TIOMA THERAPEUTICS INC1
Top patents by PatentIndex Score
20 records- 0191US10239945B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2017·Granted Mar 26, 2019·13 cites·14 claims
- 0290US10844124B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2019·Granted Nov 24, 2020·6 cites·13 claims
- 0367US9243059B2Humanized anti-N2 antibodies and methods of treating ischemia-reperfusion injuryDECIMMUNE THERAPEUTICS INC·Filed 2014·Granted Jan 26, 2016·1 cites·35 claims
- 0465US2021079091A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 0564US11692035B2Therapeutic CD47 antibodiesARCH ONCOLOGY INC·Filed 2019·Granted Jul 4, 2023·0 cites·17 claims
- 0664US2019112373A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 0764US2021070865A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 0860US2018142019A1Therapeutic cd47 antibodiesTIOMA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 0958US9409977B2Humanized, anti-N2 antibodiesDECIMMUNE THERAPEUTICS INC·Filed 2014·Granted Aug 9, 2016·0 cites·20 claims
- 1057US2022251191A1Therapeutic compositions and methods for treating cancer in combination with analogs of interleukin proteinsARCH ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 1154US2022226469A1Therapeutic sirp-alpha antibodiesARCH ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 1253US2022313819A1Combination therapy for the treatment of solid and hematological cancersARCH ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 1352US11202828B2Therapeutic SIRP-α antibodiesARCH ONCOLOGY INC·Filed 2019·Granted Dec 21, 2021·0 cites·21 claims
- 1449US2016376353A1Humanized, anti-n2 antibodiesDECIMMUNE THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1548US2021324075A1Therapeutic cd47 antibodiesARCH ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 1647US2016168238A1Humanized, anti-n2 antibodies and methods of treating ischemia-reperfusion injuryDECLMMUNE THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1746US2022185886A1Methods for identifying biomarkers to predict treatment responseARCH ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 1845US2023279108A1Therapeutic sirp-alpha antibodiesARCH ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 1944US2021395831A1Biomarkers to improve efficacy of cancer immunotherapyARCH ONCOLOGY INC·Filed 2019·Application pending·0 cites
- 2043US2019309066A1Combination therapy for the treatment of solid and hematological cancersARCH ONCOLOGY INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robyn Puro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →